Expert Market Research Explores the Top 4 Companies in the Global Intravenous Solutions Market

Ajinomoto Health & Nutrition North America, Inc., B. Braun Medical Inc., ICU Medical, Inc., and Baxter International Inc., among others, are the major players in the global intravenous solutions market.

The global intravenous solutions market size reached a value of about USD 12.16 billion in 2023. The industry is further expected to grow at a CAGR of about 7.15% in the forecast period of 2024-2032. As per the analysis by Expert Market research, the market is expected to be driven by the rise in disease prevalence, including gastrointestinal disorders, cancer, neurological disorders, and diabetes due to unhealthy dietary habits.

Since these options come in small packets, patients can use the drips at home rather than in hospitals, which is safer for them. Developing countries such as China and India are increasing their healthcare investments, which is expected to increase the demand for intravenous solutions. Manufacturers are also implementing new product technologies, such as offering premixed options for greater convenience and less packaging waste.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America is the dominant market for intravenous solutions and accounts for most of the global market share. Due to a lack of IV fluids, the regional market is being driven by the rapid increase of the manufacturing capacity in the United States of America. The development of intravenous fluids has expanded, particularly in developed countries. The United States Food and Drug Administration (FDA) and other market players, for example, have said that they are working to alleviate the crisis caused by the scarcity of IV saline. Merge, a marketing and development organisation based in the United States, teamed up with B. Braun Medical, a pioneering producer of medical products and services, to launch the omnichannel campaign 'Solutions for Life' in May 2020. This programme aimed to ensure a reliable supply of FDA-approved IV solutions in the United States.

Top 4 Global Intravenous Solutions Companies:

Ajinomoto Health & Nutrition North America, Inc.

Ajinomoto Health & Nutrition North America, Inc. is made up of 4 business divisions and 2 subsidiaries that provide innovative solutions to meet the various needs of North American consumers with better nutrition, taste, health, and wellness. The company's business divisions are solutions and ingredients, wellness and sports nutrition, amino science, and medical nutrition, and its subsidiaries are Ajinomoto Cambrooke Inc and More Than Gourmet Inc. The company specialises in amino acids, ingredient systems, speciality and personal care, and food ingredients, among others. 

B. Braun Medical Inc.

B. Braun Medical Inc., a leader in pain management and infusion therapy, develops, produces, and markets innovative medical services and products to the healthcare industry. Other key product areas include pharmacy admixture, nutrition, and dialysis. B. Braun Medical is a part of the B. Braun Group of Companies in the United States, which includes B. Braun Interventional Systems, CAPS, and Aesculap. The company specialises in infusion systems, IV therapy, vascular access, pharmacy, and regional anaesthesia, among others. 

ICU Medical, Inc.

ICU Medical connects patients and caregivers through lifesaving, safe, life-enhancing IV therapy systems, solutions, software, and consumables. With the acquisition of Hospira Infusion Systems from Pfizer in 2017, the company became the only one to focus exclusively on IV therapy across the continuum of care. The company specialises in critical care, nursing, IV therapy, healthcare informatics, hemodynamic monitoring, IV workflow software, IV safety software, and pharmaceuticals, among others.

Baxter International Inc.

Baxter International Inc. is an American multinational health care company. The company mainly focuses on products to treat kidney disease, hemophilia, immune disorders, and other acute and chronic medical conditions. The BioScience business of Baxter produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders, products for regenerative medicine, and vaccines. Medical Products business of Baxter produces intravenous products and other products used in the delivery of fluids and drugs to patients; products to treat end-stage kidney disease or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.